Advertisement

Researchers develop 3D human lung model to shed light on respiratory diseases

Researchers used the new lung "organoids", tiny 3D structures that mimic features of a full-sized lung, to generate models of human lung diseases in a lab dish.

Researchers develop 3D human lung model to shed light on respiratory diseases Image for representational purpose only

New York: A team of researchers have developed a 3D model of the human lung using pluripotent stem cells that could advance our understanding of a variety of respiratory diseases.

Researchers used the new lung "organoids", tiny 3D structures that mimic features of a full-sized lung, to generate models of human lung diseases in a lab dish.

They hope to develop better models of human diseases, and find new ways of testing drugs and regenerating damaged tissue by reproducing an organ in a dish.

Lead investigator of the study Hans-Willem Snoeck, Professor at Columbia University Medical Centre in the US said,"Researchers have taken up the challenge of creating organoids to help us understand and treat a variety of diseases."

Snoeck said, "But we have been tested by our limited ability to create organoids that can replicate key features of human disease."

The lung organoids created in Snoeck's laboratory, however, include branching airway and alveolar structures, similar to human lungs, according to a study.

To demonstrate their functionality, the researchers showed that the organoids reacted in much the same way as a real lung does when infected with respiratory syncytial virus (RSV).

Additional experiments revealed that the organoids also responded as a human lung would when carrying a gene mutation linked to pulmonary fibrosis.

Respiratory syncytial virus is a major cause of lower respiratory tract infection in infants and has no vaccine or effective antiviral therapy.

A lung transplant is currently the only cure for idiopathic pulmonary fibrosis, a condition that causes scarring in the lungs.

Snoeck said,"Organoids, created with human pluripotent or genome-edited embryonic stem cells, may be the best, and perhaps only, way to gain insight into the pathogenesis of these diseases."

The study was published in the journal Nature Cell Biology.

(With IANS inputs)